COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • November 12th, 2025 • Precision Biosciences Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 12th, 2025 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Issue Date”) and on or prior to 5:00 p.m. (New York City time) on November 12, 2030, (the “Termination Date”) but not thereafter, to subscribe for and purchase from Precision BioSciences, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, $0.000005 par value per share, of the Company (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT PDS BIOTECHNOLOGY CORPORATIONCommon Stock Purchase Warrant • November 12th, 2025 • PDS Biotechnology Corp • Pharmaceutical preparations
Contract Type FiledNovember 12th, 2025 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______, 20261 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from PDS Biotechnology Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT OSR HOLDINGS, INC.Common Stock Purchase Warrant • November 12th, 2025 • OSR Holdings, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 12th, 2025 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, WHITE LION CAPITAL, LLC, DBA WHITE LION GBM INNOVATION FUND or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until the earlier of the fifth (5th) anniversary of the Initial Exercise Date or until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from OSR HOLDINGS, INC., a Delaware corporation (the “Company”), up to the Available Share Amount (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT ANTERIS TECHNOLOGIES GLOBAL CORP.Common Stock Purchase Warrant • November 12th, 2025 • Anteris Technologies Global Corp. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledNovember 12th, 2025 Company Industry JurisdictionTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April 27, 2026 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on October 27, 2030, but not thereafter, to subscribe for and purchase from Anteris Technologies Global Corp., a Delaware corporation (the “Company”), up to _______________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.0001 per share (“Common Stock”) of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant was issued pursuant to that certain Subscription Agreement, dated as of October 23, 2025, by and between the Company and the Holder (as may be amended, amended and res